First Solar holds 2026 outlook as US trade policy reshapes solar market 
A Tale of Two Banking Markets: Texas M&A Heats Up as Deutsche Bank Treads Water 
Advancing Therapeutics and OTC Formulations: Key Updates in the Asian Pharmaceutical Sector 
Biotech Watch: Aditxt and Heidelberg Pharma Face Uphill Battle Amid Technical Slump 
Blackstone’s Next Act: Riding the $7 Trillion Data Center Wave 
Vivo’s 2026 Roadmap: A Dual 200MP Monster and a Surprise DJI Rival 
Frankfurt’s Dax Flatlines in Pre-Holiday Lull as U.S. Data Offers Mixed Signals 
Market Momentum for Specialized Funds: Latest Updates on JAAA and Aristotle Small Cap 
Leaked Sony Xperia 10 VII Renders Reveal Major Design Overhaul 
Second-quarter results and new polysilicon trade measures strengthen First Solar’s near-term position while keeping policy risk in focus.
Down in the Lone Star state, regional consolidation is still the name of the game.
The pharmaceutical landscape is currently seeing significant advancements across both clinical-stage therapeutics for neurodegenerative diseases
The biotechnology sector is seeing some turbulent price action as two notable players, Aditxt Inc.
The Power of Compounding If you threw $1,000 into Blackstone a decade ago, you’d be
Vivo appears poised to aggressively corner the imaging market in 2026, with leaks pointing to